Condition: Bronchopulmonary Dysplasia · Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Bronchopulmonary dysplasia (BPD) is a disease that affects preterm newborn patients, preventing their lungs from developing properly. Allogeneic fetal stem mesenchymal cells from umbilical cord could reduce the prevalence of BPD in this patients.
This description comes directly from the study's public registry record.
María Jesús del Cerro, PhD · 34 91 36 8000 · majecerro@yahoo.es
María Álvarez, MD · 34 9 336 8000 · mery1812@hotmail.com
Always discuss trial participation with your own doctor first.
| Hospital Quironsalud Madrid | Pozuelo de Alarcón, Madrid, Spain | Recruiting |
| Complejo Hospitalario La Coruña | A Coruña, Spain | Recruiting |
| Hospital Clínico San Carlos | Madrid, Spain | Recruiting |
| Hospital Universitario La Paz | Madrid, Spain | Recruiting |
| Hospital Universitario Carlos Haya | Málaga, Spain | Recruiting |
| Hospital Vírgen del Rocío | Seville, Spain | Recruiting |
| Hospital Universitario y Politécnico La Fe | Valencia, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06270199